Flow Traders U.S.’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Flow Traders U.S.’s Portfolio BBC Stock Details BBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$432K	Buy	+10,378	New	+$425K	0.01%	700
2022 Q2	–	Sell	-18,961	Closed	-$530K	–	811
2022 Q1	$530K	Sell	18,961 -7,525	-28%	-$223K	0.02%	539
2021 Q4	$1.02M	Sell	26,486 -14,838	-36%	-$633K	0.05%	285
2021 Q3	$1.89M	Buy	41,324 +30,846	+294%	+$1.44M	0.08%	287
2021 Q2	$523K	Buy	+10,478	New	+$513K	0.03%	581

Other funds holding BBC

KCP

Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

MCM

Militia Capital Management Austin, Texas $454M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

APW

Aurora Private Wealth Rockaway, New Jersey $140M AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

GAA

Global Assets Advisory Orlando, Florida $349M AUM 24.2% 1-Year Est. Return

Flow Traders U.S.'s BBC Position: Q1 2026 in Review

Flow Traders U.S. opened a new position in Virtus Biotech Clinical Trials ETF (BBC) in Q1 2026: 10,378 shares worth $432K. The stake represents 0.01% of the portfolio and ranks #700 among its holdings. This is a return to the name: Flow Traders U.S. previously reported a position in BBC as recently as Q1 2022.

Flow Traders U.S. first reported a position in BBC in Q2 2021 and has held it in 5 quarters since. The position peaked at $1.89M in Q3 2021. 20 funds tracked by Wall St. Rank hold BBC as of Q1 2026.

Flow Traders U.S. held 10,378 shares of Virtus Biotech Clinical Trials ETF worth $432K as of Q1 2026.
Virtus Biotech Clinical Trials ETF was a new Flow Traders U.S. position in Q1 2026.
Virtus Biotech Clinical Trials ETF made up 0.01% of Flow Traders U.S.'s portfolio in Q1 2026, its #700 holding.
Flow Traders U.S. first reported a position in Virtus Biotech Clinical Trials ETF in Q2 2021 and has held it in 5 quarters since.
Flow Traders U.S.'s Virtus Biotech Clinical Trials ETF position peaked at $1.89M in Q3 2021.
20 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q1 2026.

Based on Flow Traders U.S.'s 13F filing for Q1 2026, filed 15 May 2026.